White House nears deal with Lilly, Novo to slash obesity drug prices for Medicare
The White House is expected to announce a deal this week with Indianapolis-based Eli Lilly and Co. and with Novo Nordisk that would lower the price of their popular obesity drugs to $149 per month in some cases.... Read More
